Hepatocyte growth factor: Effects on immune-mediated heart diseases
- PMID: 16839861
- DOI: 10.1016/j.tcm.2006.03.007
Hepatocyte growth factor: Effects on immune-mediated heart diseases
Abstract
There is growing evidence of the potential role of hepatocyte growth factor (HGF) in various cardiovascular diseases. In addition to the beneficial effects of HGF in myocardial infarction, heart failure, and occlusive peripheral arterial disease, administration of HGF effectively suppresses acute and chronic cardiac allograft rejection and autoimmune myocarditis. The present review summarizes recent advances in the utility of HGF for heart diseases, especially immune-mediated heart diseases. Possible mechanisms of action in the suppression of T-cell-mediated immunity are also discussed.
Similar articles
-
Suppression of acute and chronic rejection by hepatocyte growth factor in a murine model of cardiac transplantation: induction of tolerance and prevention of cardiac allograft vasculopathy.Circulation. 2004 Sep 21;110(12):1650-7. doi: 10.1161/01.CIR.0000143052.45956.71. Epub 2004 Sep 13. Circulation. 2004. PMID: 15364799
-
Hepatocyte growth factor (HGF) as a rapid diagnostic marker and its potential in the prevention of acute renal rejection.Transpl Int. 2002 Apr;15(4):156-62. doi: 10.1007/s00147-002-0391-3. Epub 2002 Apr 6. Transpl Int. 2002. PMID: 11976737
-
Altered expression of hepatocyte growth factor in cardiac allografts of nonhuman primates.Transplant Proc. 2006 Dec;38(10):3318-20. doi: 10.1016/j.transproceed.2006.10.075. Transplant Proc. 2006. PMID: 17175260
-
[Hepatocyte growth factor and its immunoregulatory activity - review].Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Apr;15(2):441-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007. PMID: 17493366 Review. Chinese.
-
Intravenous immunoglobulin - indications and mechanisms in cardiovascular diseases.Autoimmun Rev. 2008 Jun;7(6):445-52. doi: 10.1016/j.autrev.2008.04.001. Epub 2008 Apr 30. Autoimmun Rev. 2008. PMID: 18558360 Review.
Cited by
-
Mesenchymal stromal cells but not cardiac fibroblasts exert beneficial systemic immunomodulatory effects in experimental myocarditis.PLoS One. 2012;7(7):e41047. doi: 10.1371/journal.pone.0041047. Epub 2012 Jul 17. PLoS One. 2012. PMID: 22815907 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical